Eversept Partners, LP Amarin Corp Plcuk Transaction History
Eversept Partners, LP
- $991 Million
- Q4 2024
A detailed history of Eversept Partners, LP transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Eversept Partners, LP holds 1,516,592 shares of AMRN stock, worth $15.8 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,516,592
Previous 3,309,309
54.17%
Holding current value
$15.8 Million
Previous $2.08 Million
65.12%
% of portfolio
0.07%
Previous 0.16%
Shares
46 transactions
Others Institutions Holding AMRN
# of Institutions
178Shares Held
71.2MCall Options Held
183KPut Options Held
66.7K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$259 Million3.7% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$129 Million0.38% of portfolio
-
Morgan Stanley New York, NY4.41MShares$46 Million0.0% of portfolio
-
Waterfront Wealth Inc.2.51MShares$26.2 Million5.52% of portfolio
-
Scp Investment, LP2.5MShares$26.1 Million1.0% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $4.21B
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...